HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Claus Bartels Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Christiansen, J. F. Articles by Bartels, C. Search for Related Content PubMed PubMed Citation Articles by Christiansen, J. F. Articles by Bartels, C. Related Collections Coronary disease

Ann Thorac Surg 2004;77:1575-1579
© 2004 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries

^a Department of Cardiac Surgery, Lübeck, Germany
^b Institute for Immunology and Transfusion Medicine, University Hospital, Lübeck, Germany
^c Institute of Transfusion Medicine and Clinical Immunology Mannheim, Red Cross Blood Service of Baden-Württemberg, Mannheim, Germany
^d Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

Accepted for publication October 16, 2003.

^* Address reprint requests to Dr Christiansen, Klinik für Herzchirurgie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
e-mail: janfelixchristiansen{at}gmx.de

BACKGROUND: The pathologic modifications characterizing vein graft disease resemble those observed in native arteriosclerosis, but in accelerated form. Although both disorders are considered to be inflammatory diseases, it remains to be determined whether diseased vein grafts and atherosclerotic coronary arteries differentially express inflammatory mediators. Therefore, we examined whether differences in the expression of proinflammatory cytokines by these two distinct vascular pathologies favor the accelerated inflammation within diseased vein grafts.

METHODS: The messengerRNA expression of various cytokines (interleukin-1ß [IL-1ß], IL-6, IL-8, tumor necrosis factor- [TNF-], interferon- [IFN-]) was quantified using real-time reverse transcriptase–polymerase chain reaction (RT-PCR) in tissue samples of native saphenous veins (NSV, n = 5), diseased coronary arteries (CAD, n = 25), and diseased vein grafts (VG, n = 13).

RESULTS: Native saphenous veins did not contain any detectable transcripts except for IFN-. As expected, CAD was characterized by the expression of IL-1ß, IL-6, IL-8, IFN-, and TNF- mRNA. Interestingly VG also expressed these mediators, but at markedly higher levels. Quantification by RT-PCR revealed that, compared with specimens from the CAD group, VG specimens contained 5.8 ± 1.2 times, 286 ± 22 times, and 29 ± 7.3 times as many transcripts for the cytokines IL-1ß, IL-6 and TNF-, respectively, as well as 25 ± 8.3 times more transcripts for the chemokine IL-8. In contrast, the expression of IFN- transcripts did not differ among the groups.

CONCLUSIONS: The elevated expression of proinflammatory cytokine transcripts supports the hypothesis that diseased vein grafts, compared with atherosclerotic coronary arteries, are characterized by enhanced inflammatory activity that might accelerate atherosclerotic modifications. This may implicate new therapeutic strategies for the prevention of vein graft disease.

This article has been cited by other articles:

				D. Xing, W. Feng, A. P. Miller, N. M. Weathington, Y.-F. Chen, L. Novak, J. E. Blalock, and S. Oparil Estrogen modulates TNF-{alpha}-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2607 - H2612. [Abstract] [Full Text] [PDF]

				R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF]

				A. Schepers, M.R. de Vries, C.J. van Leuven, J.M. Grimbergen, V.M. Holers, M.R. Daha, J.H. van Bockel, and P.H.A. Quax Inhibition of Complement Component C3 Reduces Vein Graft Atherosclerosis in Apolipoprotein E3-Leiden Transgenic Mice Circulation, December 19, 2006; 114(25): 2831 - 2838. [Abstract] [Full Text] [PDF]

				A. Schepers, D. Eefting, P.I. Bonta, J.M. Grimbergen, M.R. de Vries, V. van Weel, C.J. de Vries, K. Egashira, J.H. van Bockel, and P.H.A. Quax Anti-MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2063 - 2069. [Abstract] [Full Text] [PDF]

				T. Walker, H. P. Wendel, L. Tetzloff, O. Heidenreich, and G. Ziemer Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 816 - 820. [Abstract] [Full Text] [PDF]

				Z. Wang, P. J. Rao, M. R. Castresana, and W. H. Newman TNF-{alpha} induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H293 - H301. [Abstract] [Full Text] [PDF]